Metabolic Diseases Startups in Europe

There are 10 Metabolic Diseases digital health ventures in Europe. The total venture volume has expanded at a CAGR of 5.0% over the past 5 years. The ventures have an average venture maturity score of 45.3.

In total, $57.74M of digital health venture capital has been raised across 9 funding deals.

Here is a list of 10 promising HealthTech startups!

Last Updated: January 17, 2022

Ventures

Startup	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding	Track
Demiurge Technologies	Drug Discovery	Switzerland	$ 123.46 B	$ 123.46 B	Series A	$ 9.50 M	Toggle
DORPHAN	Drug Discovery	Switzerland	$ 123.46 B	$ 123.46 B		undisclosed	Toggle
Holodia SAS	Smart Equipment	Switzerland	$ 123.46 B	$ 123.46 B	Seed	$ 0.17 M	Toggle
Lyfjos	Drug Discovery	Switzerland	$ 123.46 B	$ 123.46 B		undisclosed	Toggle
MesenFlow Technologies	Drug Discovery	Switzerland	$ 123.46 B	$ 123.46 B	Grant	$ 0.01 M	Toggle
Perfood	Digital Therapeutics	Germany	$ 123.46 B	$ 123.46 B	Series A1	undisclosed	Toggle
PrecisionLife	Omics Related Research	United States	$ 123.46 B	$ 123.46 B	Series A	undisclosed	Toggle
Set Points Health	On-demand Lab Tests	United Kingdom	$ 123.46 B	$ 123.46 B		undisclosed	Toggle
Una Health	Disease Management	Germany	$ 123.46 B	$ 123.46 B		undisclosed	Toggle
Wren Therapeutics	Drug Discovery	United Kingdom	$ 123.46 B	$ 123.46 B	Series B	$ 17.12 M	Toggle

Showing 1 to 10 of 10 entries